Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
Knowledge of collection agency work, probate courts and its requirements, and bankruptcy laws and regulations Advanced written and verbal communication skills Proficient with technology, spreadsheet
-
. Human synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution. AccessHope™, a subsidiary launched in 2019 serves employers and
-
its requirements, and bankruptcy laws and regulations Advanced written and verbal communication skills Proficient with technology, spreadsheet management skills, with the ability to analyze trends
-
-paced research in cutting-edge technology, immunotherapeutic programs, and a commitment to delivering innovative solutions to critical illnesses. For more information on T Cell Therapeutics research
-
leukemogenesis as well as disease relapse in order to design novel inhibitors to intervene the malignancies · Collaborative analyses of myeloid cancers genomics using high-throughput single-cell technology
-
immune checkpoints and ligands on various hematopoietic malignant and solider tumor cells with high-throughput screening and protein engineering approaches developed in the lab, and develop novel cancer
-
synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution. AccessHope™, a subsidiary launched in 2019 serves employers and their
-
edge” and unbiased analytic tools and unique and innovative genetically engineered mouse models (please see some of the recent publications: PLoS Genet 2020 Jan 13:16(1):e1008588; Development 2021 Jan
-
, including first-in-human studies with genetically engineered hematopoietic stem and progenitor cells (HSPC) and T cells. As a successful candidate, you will: · Conduct research on next-generation
-
synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution. AccessHope™, a subsidiary launched in 2019 serves employers and their